BC
BMY icon

Brinker Capital’s Bristol-Myers Squibb BMY Stock Holding History

Brinker Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$3.57M Buy
60,651
+2,963
+5% +$177K 0.11% 186
2020
Q1 		$3.22M Sell
57,688
-683
-1% -$41.7K 0.13% 165
2019
Q4 		$3.75M Buy
58,371
+2,798
+5% +$160K 0.12% 179
2019
Q3 		$2.82M Sell
55,573
-40,790
-42% -$1.92M 0.1% 208
2019
Q2 		$4.37M Buy
96,363
+42,811
+80% +$1.99M 0.16% 135
2019
Q1 		$2.56M Buy
53,552
+8,284
+18% +$413K 0.1% 200
2018
Q4 		$2.35M Sell
45,268
-12,259
-21% -$659K 0.1% 188
2018
Q3 		$3.57M Sell
57,527
-3,152
-5% -$187K 0.13% 165
2018
Q2 		$3.36M Sell
60,679
-1,764
-3% -$95.3K 0.13% 162
2018
Q1 		$3.95M Sell
62,443
-189
-0.3% -$12.2K 0.15% 138
2017
Q4 		$3.84M Sell
62,632
-3,445
-5% -$215K 0.15% 144
2017
Q3 		$4.21M Sell
66,077
-1,232
-2% -$71.9K 0.17% 126
2017
Q2 		$3.75M Buy
67,309
+44,463
+195% +$2.42M 0.17% 136
2017
Q1 		$1.24M Sell
22,846
-2,352
-9% -$129K 0.06% 306
2016
Q4 		$1.47M Buy
+25,198
New +$1.38M 0.08% 225

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brinker Capital's BMY Position: Q2 2020 in Review

Brinker Capital increased its Bristol-Myers Squibb (BMY) stake by 5.1% in Q2 2020, buying an estimated $177K and bringing the position to 60,651 shares worth $3.57M. The position accounts for 0.11% of the portfolio, ranked #186.

Brinker Capital first reported a position in BMY in Q4 2016 and has held it in 15 quarters since. The position peaked at $4.37M in Q2 2019. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Brinker Capital held 60,651 shares of Bristol-Myers Squibb worth $3.57M as of Q2 2020.
  • Brinker Capital bought 2,963 Bristol-Myers Squibb shares in Q2 2020, an estimated $177K.
  • Bristol-Myers Squibb made up 0.11% of Brinker Capital's portfolio in Q2 2020, its #186 holding.
  • Brinker Capital first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 15 quarters since.
  • Brinker Capital's Bristol-Myers Squibb position peaked at $4.37M in Q2 2019.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.